Health Care/Hospital

IRBM Reports Breakthrough in Zika Virus Drug Discovery

ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough with the discovery of a novel and potent allosteric inhibitor targeting the Zika virus (ZIKV) protease (NS2B-NS3). The findings, published inNature Communications (do...

2026-02-10 19:00 5640

IFPA and WHO Foundation launch a strategic collaboration to strengthen global psoriasis care

GENEVA, Feb. 10, 2026 /PRNewswire/ -- The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year collaboration agreement supporting WHO efforts to strengthen global understanding, diagnosis and care for psoriasis. The collaboration aims to impro...

2026-02-10 16:42 5707

ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus

CORK, Ireland, Feb. 10, 2026 /PRNewswire/ -- ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding round, to advance its lead program ITZ-DerMap™, a novel therapeutic designed for the treatment of ...

2026-02-10 16:01 4528

From Morphology to Clinical Insights: Ozelle's AI-Powered Diagnostics at WHX Labs Dubai 2026

DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ -- As WHX Labs Dubai 2026 opens today, visitors to Booth S1.D58 are invited to see how Ozelle transforms diagnostic testing into interactive, decision-ready workflows. Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," the integrat...

2026-02-10 14:30 4015

Sky Labs Launches 'CART ON', the World's First Ring-Type Wearable Blood Pressure Monitoring Solution for Hospital Wards

- Establishment of a blood pressure monitoring lineup that addresses every environment, from daily life to hospital wards SEOUL, South Korea, Feb. 10, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 10th that it has launched 'CART ON', the world's first ward-specific bloo...

2026-02-10 13:26 5292

Malaysia's First Large Language Model based Synthetic Data Intelligence Platform with Agentic function, AxxonAI launched with healthcare partner Sancy Berhad

* Empowering ASEAN & global businesses to make sound data-driven decisions while ensuring privacy and compliance KUALA LUMPUR, Malaysia, Feb. 10, 2026 /PRNewswire/ -- Athenatech AI Sdn Berhad (athenatech.ai ), one of Malaysia's top six AI start-ups to watch, today announced the launch of subsid...

2026-02-10 13:10 6244

Silklife: Chula Researchers Transform Thai Silk into Medical Innovation

BANGKOK, Feb. 10, 2026 /PRNewswire/ -- Researchers at Chulalongkorn University  are redefining the role of Thai silk by developing silk protein into a versatile platform for medical products, aiming to reduce Thailand's reliance on imported biomaterials while creating...

2026-02-10 10:00 4805

SilkLife: Chula Researchers Transform Thai Silk into Medical Innovation

BANGKOK, Feb. 10, 2026 /PRNewswire/ -- Researchers at Chulalongkorn University are redefining the role of Thai silk by developing silk protein into a versatile platform for medical products, aiming to reduce Thailand's reliance on imported biomaterials while creating...

2026-02-10 10:00 7847

Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial.

ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided surgery solution for hard-to-treat cancers. The technology ...

2026-02-10 09:30 5183

Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia

The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve. SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Today, Johns...

2026-02-10 08:30 3908

Australia and New Zealand's Skin Cancer Governance Gap Exposed: 40% of Organisations Never Assessed Workforce Risk Despite 84% Believing Duty of Care Applies

New research reveals a critical blind spot in workplace health and safety compliance - even as boards demand better programs SYDNEY, Feb. 10, 2026 /PRNewswire/ -- A comprehensive new report on workplace skin cancer  screening in Australia ...

2026-02-10 06:23 4215

MALAYSIA HEALTHCARE STRENGTHENS CROSS-BORDER COLLABORATION THROUGH STRATEGIC PARTNERSHIP WITH ONEHEALTH CAMBODIA

PHNOM PENH, Cambodia, Feb. 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked the launch of Malaysia Healthcare Week Phnom Penh 2026 with a hospital introduction session in collaboration with OneHealth Cambodia. This engagement represents MHTC's first official initiative in ...

2026-02-09 22:00 6515

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

* Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors * Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications * Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advance...

2026-02-09 21:44 8280

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai

MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinar...

2026-02-09 20:36 4916

AIA RESEARCH REVEALS INGRAINED HEALTH STEREOTYPES ARE HOLDING BACK WELLBEING IN ASIA

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- AIA Group Limited ("AIA" or the "Group") today releases new research revealing that deeply entrenched physical, mental and financial health stereotypes shape attitudes and behaviours around wellbeing across Asia. The study(1) was conducted across Mainland C...

2026-02-09 16:08 15197

CEVA ANNOUNCES STRATEGIC LEADERSHIP CHANGES IN ASIA-PACIFIC AND CHINA

LIBOURNE, France, Feb. 9, 2026 /PRNewswire/ -- Ceva Animal Health (Ceva), the world's fifth-largest animal health company operating in 110 countries, is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operat...

2026-02-09 14:00 6295

Angel Yeast Indonesia Project: Strengthening Foundations through Technical Training and Building Consensus through Cultural Exchange

YICHANG, China, Feb. 6, 2026 /PRNewswire/ -- Angel Yeast Group (SH600298) recently welcomed 29 employees from Indonesia to its headquarters in Yichang, China, for a six-month structured training program. The initiative is designed to develop a cohort of skilled profes...

2026-02-07 09:31 18779

CHANDO Presents Decade-Long Skin Brightening Research at IMCAS

Research Introduces 577 Epigenetic Mechanism for Asian Skin SHANGHAI, Feb. 7, 2026 /PRNewswire/ -- The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Paris. As a global platform supporting collaboration in derm...

2026-02-07 01:45 6362

Kolmar Korea Wins Legal Battle Over Sun Care Technology Leakage Against Intercos Korea

- Korean courts order Intercos Korea to bear full legal costs, affirming both civil and criminal liability SEOUL, South Korea, Feb. 6, 2026 /PRNewswire/ -- Kolmar Korea has secured a decisive legal victory in a long-running dispute over the illegal leakage of proprietary sun care technologies in...

2026-02-06 21:30 8011

Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer

CHENGDU, China, Feb. 6, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-directed ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) has been approv...

2026-02-06 17:00 6503
1 ... 891011121314 ... 545